Dr. Vinod Trivedi, MD

Dr. Trivedi practices at Sutter Roseville Medical Center in Roseville, California, part of Sutter Health.

Dr. Trivedi's NPI, 1003001645, was assigned on September 6, 2007. Dr. Trivedi holds California license GJ218Z.

Dr. Trivedi's primary practice is Sutter Roseville Medical Center, at One Medical Plaza, Roseville, CA 95661 in Placer County. The practice phone is (916) 781-1000. Dr. Trivedi also practices at Sutter Roseville Medical Center, 1 Medical Plz, Roseville, CA 95661.

Dr. Trivedi's primary practice is Sutter Roseville Medical Center in Roseville, California, part of Sutter Health. Dr. Trivedi is also affiliated with Sutter Medical Center, Sacramento. The medical group on file is Pulmonary Medicine Associates. Dmand AI also links Dr. Trivedi to 3 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Trivedi practices, 7 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Trivedi's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Trivedi is board certified in infectious disease by the American Board of Internal Medicine. Dr. Trivedi is licensed in California.

CMS data shows 1,010 Medicare services from Dr. Trivedi across 6 procedure codes in 2024, for 454 Medicare patients. Medicare paid $117,047 for them.

CMS counts 454 Medicare patients who saw Dr. Trivedi in 2024. The largest group is 65 to 74, with 151 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 3.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Trivedi's median patient age at 65, with 43% women.

In 2024, Dr. Trivedi wrote 942 Medicare Part D claims for 145 patients. 72% of them were for generic drugs. CMS names the drug for 831 of them, across 28 drugs with 11 or more claims each, at $789,061 in total drug cost. In 2023, CMS named 797 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Trivedi for performance year 2024, reported as part of a group. Dr. Trivedi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Trivedi as offering telehealth.

CMS Open Payments shows 396 general payments to Dr. Trivedi from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Gilead Sciences, Inc. paid the most, $1,552.